What is the predictive value of preoperative CA 125 level on the survival rate of type 1 endometrial cancer?
- PMID: 32979897
- PMCID: PMC7991883
- DOI: 10.3906/sag-2005-331
What is the predictive value of preoperative CA 125 level on the survival rate of type 1 endometrial cancer?
Abstract
Background/aim: To investigate the utility of preoperative serum cancer antigen 125 (CA 125) levels in type 1 endometrial carcinoma (EC) as a marker for determining poor prognostic factors and survival.
Material and methods: All patients with endometrial cancer, who had been treated between 2012 and 2020, were retrospectively reviewed, and finally, 256 patients with type 1 endometrium carcinoma were included in the study. The relationship between the clinicopathological characteristics, CA 125 level, and survival rates were analyzed. The cut-off value for the preoperative serum CA 125 level was defined as 16 IU/L.
Results: The median serum CA 125 levels were significantly higher in patients with deep myometrial invasion, lymph node metastasis, lymphovascular space invasion, cervical stromal and adnexal involvement, advanced stage, positive peritoneal cytology, recurrence, and adjuvant therapy requirement. Serum CA 125 cut-off values determined according to clinicopathologic factors ranged from 15.3 to 22.9 IU/L (sensitivity 61%–77%, specificity 52%–73%). The disease-specific survival rate was significantly higher in patients with CA 125 levels < 16 IU/L (P = 0.047).
Conclusion: The data showed that choosing a lower threshold value for the CA 125 level (16 IU/L) instead of 35 IU/L, could be more useful in type 1 EC patients with negative prognostic factors.
Keywords: cut-off value; endometrial carcinoma; prognosis; survival; Cancer antigen 125 (CA 125).
This work is licensed under a Creative Commons Attribution 4.0 International License.
Conflict of interest statement
The authors declare that there are no conflicts of interest.
Figures
Similar articles
-
The Value of Preoperative CA 125 Levels in Prediction of Myometrial Invasion in Patients with Early-stage Endometrioid- type Endometrial Cancer.Asian Pac J Cancer Prev. 2016;17(2):497-501. doi: 10.7314/apjcp.2016.17.2.497. Asian Pac J Cancer Prev. 2016. PMID: 26925634
-
Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer.J Obstet Gynaecol Can. 2011 Aug;33(8):844-850. doi: 10.1016/S1701-2163(16)34988-X. J Obstet Gynaecol Can. 2011. PMID: 21846440
-
Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.Acta Obstet Gynecol Scand. 2006;85(12):1501-5. doi: 10.1080/00016340601022777. Acta Obstet Gynecol Scand. 2006. PMID: 17260229
-
HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.Gynecol Oncol. 2021 Feb;160(2):514-519. doi: 10.1016/j.ygyno.2020.11.004. Epub 2020 Nov 16. Gynecol Oncol. 2021. PMID: 33213897
-
Diagnostic Accuracy of Clinical Biomarkers for Preoperative Prediction of Lymph Node Metastasis in Endometrial Carcinoma: A Systematic Review and Meta-Analysis.Oncologist. 2019 Sep;24(9):e880-e890. doi: 10.1634/theoncologist.2019-0117. Epub 2019 Jun 11. Oncologist. 2019. PMID: 31186375 Free PMC article.
Cited by
-
Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.Rev Assoc Med Bras (1992). 2024 May 20;70(5):e20231115. doi: 10.1590/1806-9282.20231115. eCollection 2024. Rev Assoc Med Bras (1992). 2024. PMID: 38775501 Free PMC article.
-
Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer.Oncol Lett. 2023 Sep 13;26(5):463. doi: 10.3892/ol.2023.14050. eCollection 2023 Nov. Oncol Lett. 2023. PMID: 37854864 Free PMC article.
-
Prognostic significance of systemic inflammatory response markers NLR, PLR, and MLR in advanced high-risk endometrial cancer following radiotherapy.Am J Cancer Res. 2025 Mar 15;15(3):966-975. doi: 10.62347/YYNW9957. eCollection 2025. Am J Cancer Res. 2025. PMID: 40226458 Free PMC article.
-
Endometrial thickness and uterine artery Doppler parameters as soft markers for prediction of endometrial cancer in postmenopausal bleeding women: a cross-sectional study at tertiary referral hospitals from Vietnam.Obstet Gynecol Sci. 2022 Sep;65(5):430-440. doi: 10.5468/ogs.22053. Epub 2022 Apr 29. Obstet Gynecol Sci. 2022. PMID: 35488358 Free PMC article.
References
-
- Miller KD Nogueira L Mariotto AB Rowland JH Yabroff KR Cancer treatment and survivorship statistics 2019. CA:A Cancer Journal for Clinicians . 2019;69:363–385. - PubMed
-
- Ferguson SE Olshen AB Viale A Barakat RR Boyd J Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles. Clinical Cancer Research . 2005;11:2252–2257. - PubMed
-
- Duk JM Aalders JG Fleuren GJ A useful marker in endometrial carcinoma. American Journal of Obstetrics & Gynecology . 1986;155:1097–1102. - PubMed
-
- Patsner B Mann WJ Cohen H Loesch M. Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma. American Journal of Obstetrics & Gynecology . 1988;158:399–402. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials